Western Union Responds to Typhoon Haiyan with Support for Relief Efforts

The Western Union Company today announced a multi-faceted response program that will provide support for disaster relief efforts that target the families and communities most affected by Typhoon Haiyan in the Philippines. The program includes grant funding from The Western Union Foundation and a consumer no-fee* activation initiative, as well as Western Union employee and retail Agent giving elements.

Otsuka Receives Opinion from CHMP on Delamanid

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for delamanid for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) in combination with an optimised background regimen (OBR) according to WHO guidelines in patients. The CHMP considered that the duration of treatment (two months) in the Phase IIb randomised controlled trial (Trial 204) was too short to establish the effectiveness of delamanid in treating tuberculosis when added to other anti-tuberculosis medicines.